Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page has removed the contact information for the Principal Investigator, Vijay Ramaswamy, and the recruiting section, while adding new dates related to the project.SummaryDifference0.5%
- Check18 days agoChange DetectedThe page has added new contact information for two Principal Investigators, Alicia Lenzen and Anna Vinitsky, and updated the dates related to the content. Additionally, a previous date has been removed.SummaryDifference0.9%
- Check25 days agoChange DetectedThe page has been updated with new dates and a status change to 'Suspended', while several previous contact details and principal investigator names have been removed.SummaryDifference2%
- Check32 days agoChange DetectedDifference0.1%
- Check39 days agoChange DetectedThe page has updated its service availability information, indicating that some NLM-NCBI services are experiencing heavy traffic, which may impact performance. Additionally, several dates have been added while others have been removed.SummaryDifference1%
- Check46 days agoChange DetectedThe website has added new dates for 2025 and 2026, along with an update to version v2.14.2, while removing several earlier dates and reverting to version v2.14.1.SummaryDifference0.4%
Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.